MapLight Therapeutics, Inc.
MPLT
$30.67
$0.371.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 808.62% | 7.94% | -12.11% | -4.77% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 266.06% | 50.75% | 53.44% | 22.04% | |
| Operating Income | -266.06% | -50.75% | -53.44% | -22.04% | |
| Income Before Tax | -274.71% | -54.70% | -62.21% | -17.98% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -274.71% | -54.70% | -62.21% | -17.98% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -274.71% | -54.70% | -62.21% | -17.98% | |
| EBIT | -266.06% | -50.75% | -53.44% | -22.04% | |
| EBITDA | -268.58% | -51.46% | -54.09% | -22.11% | |
| EPS Basic | 91.15% | -48.26% | -60.91% | -3.71% | |
| Normalized Basic EPS | 91.16% | -48.26% | -58.36% | -3.71% | |
| EPS Diluted | 91.15% | -48.26% | -60.91% | -3.71% | |
| Normalized Diluted EPS | 91.16% | -48.26% | -58.36% | -3.71% | |
| Average Basic Shares Outstanding | 4,131.80% | 4.34% | 0.81% | 13.76% | |
| Average Diluted Shares Outstanding | 4,131.80% | 4.34% | 0.81% | 13.76% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |